Sign In
Buy APRE
$0.762
-0.0022 (-0.288%)
At Close: Jun 03, 2026
BOSTON, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the
3 Stocks with Jaw-Dropping Growth Potential
10:00am, Monday, 23'rd Nov 2020
Aprea Therapeutics, Viking Therapeutics, and Vaxart could all generate life-changing returns for early shareholders.
Aprea Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference
08:00am, Thursday, 19'th Nov 2020
BOSTON, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the
Aprea Therapeutics Reports Third Quarter 2020 Financial Results and Provides Update on Business Operations
04:15pm, Thursday, 05'th Nov 2020
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the
BOSTON, Oct. 30, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics to reactivate mutant
Gilead Announces New Data on Biktarvy® for the Treatment of HIV in Black Americans
12:00am, Wednesday, 21'st Oct 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced 48-week data from the BRAAVE 2020 study, a Phase 3 clinical trial evaluating the safety and effic
Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020
12:00am, Monday, 19'th Oct 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of 18 abstracts spanning the company’s HIV treatment and prevention and COVID-19
A new revolutionary alternative for the people of Venezuela
10:54am, Tuesday, 13'th Oct 2020
BEN LUNN and PAUL DOBSON report on a re-alignment of left forces in Venezuela
The Global Generator Rental Market for Oil and Gas Industry will grow by $ 153.87 mn during 2020-2024
Gilead Presents Biktarvy® Findings From Switch Studies & Analysis of Real-World BICSTaR Study At HIV Glasgow 2020
10:00am, Monday, 05'th Oct 2020
Gilead Sciences, Inc. (Nasdaq: GLD) today announced long-term study results, which showed that people living with HIV who switched to the once-daily, single...
Oct 05, 2020 (The Expresswire) --
Global “Temporary Power Market” report gives a historical overview of the Temporary Power market trends, growth, revenue,...
Gilead Presents Biktarvy® Findings From Switch Studies & Analysis of Real-World BICSTaR Study At HIV Glasgow 2020
12:00am, Monday, 05'th Oct 2020
Gilead Sciences, Inc. (Nasdaq: GLD) today announced long-term study results, which showed that people living with HIV who switched to the once-daily,
Gilead Sciences Presents Data From HIV Research and Development Programs at HIV Glasgow 2020
12:37pm, Wednesday, 30'th Sep 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the HIV Glasgow 2020 conference, taking place virtually from October 5-8....
Sep 30, 2020 (AmericaNewsHour) --
The Global Power Rental Market was valued at USD 12.62 billion in 2016 and is projected to reach USD 26.36 billion by 2025,...
Gilead Sciences Presents Data From HIV Research and Development Programs at HIV Glasgow 2020
12:00am, Wednesday, 30'th Sep 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the HIV Glasgow 2020 conference, taking place virtually from Octobe
